TLCR Reading Tools
How to cite item
ADK-VR2, a cell line derived from a treatment-naïve patient with
SDC4-ROS1
fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{69744}, author = {Ruzzi, F., Angelicola, S., Landuzzi, L., Nironi, E., Semprini, M., Scalambra, L., Altimari, A., Gruppioni, E., Fiorentino, M., Giunchi, F., Ferracin, M., Astolfi, A., Indio, V., Ardizzoni, A., Gelsomino, F., Nanni, P., Lollini, P., Palladini, A.}, title = {ADK-VR2, a cell line derived from a treatment-naïve patient with <em>SDC4-ROS1</em> fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC}, journal = {Translational Lung Cancer Research}, volume = {11}, number = {11}, year = {2022}, url = {https://tlcr.amegroups.org/article/view/69744} }